Search research articles
Contact Us
Filters
Showing results (161-170 of 167) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 167 results.
Cancer Letters
|
January 10, 2024
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment
Florencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 30, 2023
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
George J Kahaly, Peter J Dolman, Jan Wolf, et al.
Cancer Research
|
February 1, 2025
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition
Florencia P Madorsky Rowdo, Rachel Martini, Sarah E Ackermann, et al.
Nature Communications
|
May 26, 2026
Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study
Ezequiel Dantas, Katie C Hootman, Jenna Moyer, et al.
JAMA
|
July 30, 2025
Influenza-Associated Acute Necrotizing Encephalopathy in US Children
, Andrew Silverman, Rachel Walsh, et al.
Science Advances
|
June 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities
Hui-Hsuan Kuo, Bhavneet Bhinder, Hamza N Gokozan, et al.
Science (New York, N.Y.)
|
December 8, 2009
The B73 maize genome: complexity, diversity, and dynamics
Patrick S Schnable, Doreen Ware, Robert S Fulton, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 167) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 167 results.
Cancer Letters
|
January 10, 2024
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment
Florencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 30, 2023
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
George J Kahaly, Peter J Dolman, Jan Wolf, et al.
Cancer Research
|
February 1, 2025
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition
Florencia P Madorsky Rowdo, Rachel Martini, Sarah E Ackermann, et al.
Nature Communications
|
May 26, 2026
Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study
Ezequiel Dantas, Katie C Hootman, Jenna Moyer, et al.
JAMA
|
July 30, 2025
Influenza-Associated Acute Necrotizing Encephalopathy in US Children
, Andrew Silverman, Rachel Walsh, et al.
Science Advances
|
June 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities
Hui-Hsuan Kuo, Bhavneet Bhinder, Hamza N Gokozan, et al.
Science (New York, N.Y.)
|
December 8, 2009
The B73 maize genome: complexity, diversity, and dynamics
Patrick S Schnable, Doreen Ware, Robert S Fulton, et al.
Page
of 17